Work

HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction

Year: 2014

Type: article

Source: Diabetes

DOI: 10.2337/db14-0472

Authors: Lea Rahtu-Korpela, Sara Karsikas, Sohvi Hörkkö, Roberto Blanco Sequeiros, Eveliina Lammentausta, Kari A. Mäkelä, Karl-Heinz Herzig, Gail Walkinshaw, Kari I. Kivirikko, Johanna Myllyharju, Raisa Serpi, Peppi Koivunen

Institutions: University of Oulu, Oulu University Hospital, NordLab, FibroGen (United States)

Language: English

Topic: Adipokines, Inflammation, and Metabolic Diseases

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2171230374

FWCI: 6.758

Cites: 34

Cited by: 120

Related to: 10